- Your cart is empty
- Continue Shopping
FDA
- FDA
- Posted on
-
by admin
- 0 comments
- FDA Adds Warning About Rare Occurrence of Serious Liver Injury with Use of Veozah (fezolinetant) for Hot Flashes Due to Menopause. Stop Medicine if Signs and Symptoms of Liver Injury Occur – Drug Safety Communicationby FDA on September 12, 2024 at 5:00 pm
The FDA is warning that Veozah (fezolinetant), a medicine used to treat hot flashes due to menopause, can cause rare but serious liver injury. If there are signs and symptoms suggesting liver injury, stopping the medicine could prevent worsening liver injury.
- Related Recalls – Plastic Syringes Made in China for Potential Device Failuresby FDA on September 10, 2024 at 4:00 am
Related Recalls – Plastic Syringes Made In China for Potential Device Failures
- UPDATE: Evaluating Plastic Syringes Made in China for Potential Device Failures: FDA Safety Communicationby FDA on September 6, 2024 at 4:00 am
UPDATE: Evaluating Plastic Syringes Made in China for Potential Device Failures: FDA Safety Communication
- Laryngoscope Recall: Medtronic Removes Certain McGrath MAC Video Laryngoscopes, Updates Use Instructions for Others due to Increased Risk for Battery Overheat and Explosionby FDA on September 5, 2024 at 4:00 am
McGrath MAC Video Laryngoscopes help visualize the trachea and larynx. The batteries on these devices may deplete too much, causing overheating and explosion.
- Continuous Glucose Monitoring (CGM) Sensor Recall: Abbott Diabetes Care Inc Issues Recall for Certain FreeStyle Libre 3 Sensors due to Risk for Inaccurate High Glucose Readingsby FDA on September 5, 2024 at 4:00 am
FreeStyle Libre 3 sensor provides continuous monitoring of glucose levels but a small number of sensors may give inaccurate high readings
